nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—MTHFR—obesity	0.222	0.75	CbGaD
Methotrexate—SLC22A11—Cimetidine—obesity	0.0833	0.32	CbGbCtD
Methotrexate—SLC22A7—Cimetidine—obesity	0.0793	0.305	CbGbCtD
Methotrexate—ALB—obesity	0.0741	0.25	CbGaD
Methotrexate—SLC22A8—Cimetidine—obesity	0.0484	0.186	CbGbCtD
Methotrexate—SLC22A6—Cimetidine—obesity	0.0337	0.13	CbGbCtD
Methotrexate—ABCB1—Cimetidine—obesity	0.015	0.0578	CbGbCtD
Methotrexate—Tetrahydrofolic acid—ALDH1L1—obesity	0.00373	0.773	CrCbGaD
Methotrexate—ABCC2—bile—obesity	0.00283	0.0332	CbGeAlD
Methotrexate—FOLR1—respiratory system—obesity	0.00193	0.0227	CbGeAlD
Methotrexate—TYMS—Alverine—Benzphetamine—obesity	0.00139	1	CbGdCrCtD
Methotrexate—FOLR1—pituitary gland—obesity	0.00131	0.0154	CbGeAlD
Methotrexate—FPGS—islet of Langerhans—obesity	0.0012	0.0141	CbGeAlD
Methotrexate—SLC19A1—adipose tissue—obesity	0.00115	0.0135	CbGeAlD
Methotrexate—FPGS—respiratory system—obesity	0.00113	0.0133	CbGeAlD
Methotrexate—SLC46A1—adrenal cortex—obesity	0.0011	0.0129	CbGeAlD
Methotrexate—ATIC—respiratory system—obesity	0.00109	0.0129	CbGeAlD
Methotrexate—SLC19A1—digestive system—obesity	0.00108	0.0127	CbGeAlD
Methotrexate—SLC19A1—adrenal gland—obesity	0.00103	0.0121	CbGeAlD
Methotrexate—FOLR1—endocrine gland—obesity	0.00102	0.0119	CbGeAlD
Methotrexate—AOX1—gall bladder—obesity	0.001	0.0118	CbGeAlD
Methotrexate—ABCC3—gall bladder—obesity	0.000982	0.0115	CbGeAlD
Methotrexate—ABCC11—endocrine gland—obesity	0.000974	0.0115	CbGeAlD
Methotrexate—FPGS—adrenal cortex—obesity	0.000948	0.0112	CbGeAlD
Methotrexate—SLC19A1—endocrine gland—obesity	0.000891	0.0105	CbGeAlD
Methotrexate—SLC46A1—pituitary gland—obesity	0.000886	0.0104	CbGeAlD
Methotrexate—ABCC11—liver—obesity	0.000878	0.0103	CbGeAlD
Methotrexate—GGH—pituitary gland—obesity	0.000872	0.0102	CbGeAlD
Methotrexate—GGH—adipose tissue—obesity	0.000868	0.0102	CbGeAlD
Methotrexate—ALB—gall bladder—obesity	0.000837	0.00985	CbGeAlD
Methotrexate—ATIC—cardiovascular system—obesity	0.000837	0.00984	CbGeAlD
Methotrexate—SLC46A1—digestive system—obesity	0.000831	0.00977	CbGeAlD
Methotrexate—GGH—digestive system—obesity	0.000817	0.00961	CbGeAlD
Methotrexate—MTHFR—respiratory system—obesity	0.000812	0.00955	CbGeAlD
Methotrexate—SLC19A1—liver—obesity	0.000803	0.00945	CbGeAlD
Methotrexate—SLC46A1—adrenal gland—obesity	0.000792	0.00931	CbGeAlD
Methotrexate—GGH—adrenal gland—obesity	0.000779	0.00916	CbGeAlD
Methotrexate—FPGS—pituitary gland—obesity	0.000766	0.00901	CbGeAlD
Methotrexate—FPGS—adipose tissue—obesity	0.000763	0.00897	CbGeAlD
Methotrexate—SLCO1B3—pituitary gland—obesity	0.000751	0.00883	CbGeAlD
Methotrexate—PGD—islet of Langerhans—obesity	0.000747	0.00878	CbGeAlD
Methotrexate—TYMS—respiratory system—obesity	0.000741	0.00871	CbGeAlD
Methotrexate—ATIC—adipose tissue—obesity	0.000738	0.00868	CbGeAlD
Methotrexate—DHFR—respiratory system—obesity	0.000734	0.00863	CbGeAlD
Methotrexate—FPGS—digestive system—obesity	0.000718	0.00845	CbGeAlD
Methotrexate—PGD—respiratory system—obesity	0.000706	0.0083	CbGeAlD
Methotrexate—ATIC—digestive system—obesity	0.000695	0.00817	CbGeAlD
Methotrexate—SLC46A1—endocrine gland—obesity	0.000686	0.00807	CbGeAlD
Methotrexate—FPGS—adrenal gland—obesity	0.000685	0.00805	CbGeAlD
Methotrexate—GGH—endocrine gland—obesity	0.000675	0.00794	CbGeAlD
Methotrexate—ATIC—adrenal gland—obesity	0.000662	0.00778	CbGeAlD
Methotrexate—AOX1—islet of Langerhans—obesity	0.000658	0.00774	CbGeAlD
Methotrexate—MTHFR—cardiovascular system—obesity	0.000622	0.00731	CbGeAlD
Methotrexate—SLC46A1—liver—obesity	0.000619	0.00728	CbGeAlD
Methotrexate—SLCO1C1—pituitary gland—obesity	0.000616	0.00724	CbGeAlD
Methotrexate—DHFR—adrenal cortex—obesity	0.000616	0.00724	CbGeAlD
Methotrexate—SLCO1C1—adipose tissue—obesity	0.000614	0.00722	CbGeAlD
Methotrexate—GGH—liver—obesity	0.000609	0.00716	CbGeAlD
Methotrexate—ABCC3—respiratory system—obesity	0.000608	0.00715	CbGeAlD
Methotrexate—FPGS—endocrine gland—obesity	0.000594	0.00698	CbGeAlD
Methotrexate—PGD—adrenal cortex—obesity	0.000592	0.00696	CbGeAlD
Methotrexate—SLCO1B3—endocrine gland—obesity	0.000582	0.00684	CbGeAlD
Methotrexate—ATIC—endocrine gland—obesity	0.000574	0.00675	CbGeAlD
Methotrexate—DHFR—cardiovascular system—obesity	0.000562	0.00661	CbGeAlD
Methotrexate—SLC22A11—digestive system—obesity	0.000561	0.0066	CbGeAlD
Methotrexate—MTHFR—adipose tissue—obesity	0.000549	0.00645	CbGeAlD
Methotrexate—SLC22A7—digestive system—obesity	0.000548	0.00644	CbGeAlD
Methotrexate—SLCO3A1—pituitary gland—obesity	0.000542	0.00637	CbGeAlD
Methotrexate—PGD—cardiovascular system—obesity	0.00054	0.00635	CbGeAlD
Methotrexate—SLCO4C1—liver—obesity	0.00054	0.00635	CbGeAlD
Methotrexate—SLCO3A1—adipose tissue—obesity	0.00054	0.00635	CbGeAlD
Methotrexate—FPGS—liver—obesity	0.000535	0.00629	CbGeAlD
Methotrexate—SLCO1B3—liver—obesity	0.000525	0.00617	CbGeAlD
Methotrexate—AOX1—adrenal cortex—obesity	0.000522	0.00613	CbGeAlD
Methotrexate—ATIC—liver—obesity	0.000518	0.00609	CbGeAlD
Methotrexate—MTHFR—digestive system—obesity	0.000516	0.00607	CbGeAlD
Methotrexate—ABCC3—adrenal cortex—obesity	0.00051	0.006	CbGeAlD
Methotrexate—ABCC10—adrenal cortex—obesity	0.000508	0.00597	CbGeAlD
Methotrexate—SLC16A1—cardiovascular system—obesity	0.000504	0.00593	CbGeAlD
Methotrexate—TYMS—adipose tissue—obesity	0.000501	0.00589	CbGeAlD
Methotrexate—DHFR—pituitary gland—obesity	0.000498	0.00585	CbGeAlD
Methotrexate—DHFR—adipose tissue—obesity	0.000496	0.00583	CbGeAlD
Methotrexate—MTHFR—adrenal gland—obesity	0.000492	0.00579	CbGeAlD
Methotrexate—SLCO3A1—adrenal gland—obesity	0.000484	0.00569	CbGeAlD
Methotrexate—PGD—pituitary gland—obesity	0.000478	0.00563	CbGeAlD
Methotrexate—SLCO1C1—endocrine gland—obesity	0.000477	0.00561	CbGeAlD
Methotrexate—PGD—adipose tissue—obesity	0.000477	0.0056	CbGeAlD
Methotrexate—TYMS—digestive system—obesity	0.000471	0.00554	CbGeAlD
Methotrexate—DHFR—digestive system—obesity	0.000467	0.00549	CbGeAlD
Methotrexate—SLC22A11—endocrine gland—obesity	0.000464	0.00545	CbGeAlD
Methotrexate—SLC22A7—endocrine gland—obesity	0.000453	0.00532	CbGeAlD
Methotrexate—TYMS—adrenal gland—obesity	0.000449	0.00528	CbGeAlD
Methotrexate—PGD—digestive system—obesity	0.000449	0.00527	CbGeAlD
Methotrexate—SLC16A1—pituitary gland—obesity	0.000447	0.00525	CbGeAlD
Methotrexate—SLC16A1—adipose tissue—obesity	0.000445	0.00523	CbGeAlD
Methotrexate—DHFR—adrenal gland—obesity	0.000445	0.00523	CbGeAlD
Methotrexate—PGD—adrenal gland—obesity	0.000427	0.00503	CbGeAlD
Methotrexate—MTHFR—endocrine gland—obesity	0.000427	0.00502	CbGeAlD
Methotrexate—AOX1—pituitary gland—obesity	0.000422	0.00496	CbGeAlD
Methotrexate—Folic Acid—MTHFR—obesity	0.00042	0.0872	CrCbGaD
Methotrexate—Tetrahydrofolic acid—MTHFR—obesity	0.00042	0.0872	CrCbGaD
Methotrexate—SLCO3A1—endocrine gland—obesity	0.00042	0.00494	CbGeAlD
Methotrexate—AOX1—adipose tissue—obesity	0.00042	0.00494	CbGeAlD
Methotrexate—SLC16A1—digestive system—obesity	0.000419	0.00492	CbGeAlD
Methotrexate—SLC22A11—liver—obesity	0.000418	0.00491	CbGeAlD
Methotrexate—ABCC3—adipose tissue—obesity	0.000411	0.00483	CbGeAlD
Methotrexate—ABCC10—pituitary gland—obesity	0.00041	0.00482	CbGeAlD
Methotrexate—ABCC10—adipose tissue—obesity	0.000409	0.0048	CbGeAlD
Methotrexate—SLC22A7—liver—obesity	0.000408	0.0048	CbGeAlD
Methotrexate—SLCO1B1—digestive system—obesity	0.000407	0.00479	CbGeAlD
Methotrexate—SLC16A1—adrenal gland—obesity	0.000399	0.00469	CbGeAlD
Methotrexate—AOX1—digestive system—obesity	0.000395	0.00465	CbGeAlD
Methotrexate—TYMS—endocrine gland—obesity	0.000389	0.00458	CbGeAlD
Methotrexate—ABCC3—digestive system—obesity	0.000387	0.00454	CbGeAlD
Methotrexate—DHFR—endocrine gland—obesity	0.000386	0.00453	CbGeAlD
Methotrexate—MTHFR—liver—obesity	0.000385	0.00452	CbGeAlD
Methotrexate—ABCC10—digestive system—obesity	0.000385	0.00452	CbGeAlD
Methotrexate—SLCO3A1—liver—obesity	0.000379	0.00445	CbGeAlD
Methotrexate—AOX1—adrenal gland—obesity	0.000377	0.00443	CbGeAlD
Methotrexate—PGD—endocrine gland—obesity	0.000371	0.00436	CbGeAlD
Methotrexate—ABCC3—adrenal gland—obesity	0.000368	0.00433	CbGeAlD
Methotrexate—ABCC10—adrenal gland—obesity	0.000367	0.00431	CbGeAlD
Methotrexate—ABCC1—adrenal cortex—obesity	0.000359	0.00422	CbGeAlD
Methotrexate—TYMS—liver—obesity	0.000351	0.00413	CbGeAlD
Methotrexate—DHFR—liver—obesity	0.000348	0.00409	CbGeAlD
Methotrexate—SLC16A1—endocrine gland—obesity	0.000346	0.00407	CbGeAlD
Methotrexate—ABCC4—adipose tissue—obesity	0.000339	0.00398	CbGeAlD
Methotrexate—SLCO1B1—endocrine gland—obesity	0.000337	0.00396	CbGeAlD
Methotrexate—PGD—liver—obesity	0.000334	0.00393	CbGeAlD
Methotrexate—SLCO1A2—digestive system—obesity	0.000332	0.0039	CbGeAlD
Methotrexate—AOX1—endocrine gland—obesity	0.000327	0.00384	CbGeAlD
Methotrexate—ABCC3—endocrine gland—obesity	0.000319	0.00376	CbGeAlD
Methotrexate—ABCC4—digestive system—obesity	0.000319	0.00375	CbGeAlD
Methotrexate—ABCC10—endocrine gland—obesity	0.000318	0.00374	CbGeAlD
Methotrexate—ALB—adrenal gland—obesity	0.000314	0.00369	CbGeAlD
Methotrexate—SLC16A1—liver—obesity	0.000312	0.00367	CbGeAlD
Methotrexate—ABCC2—digestive system—obesity	0.000309	0.00363	CbGeAlD
Methotrexate—ABCC4—adrenal gland—obesity	0.000304	0.00357	CbGeAlD
Methotrexate—SLCO1B1—liver—obesity	0.000303	0.00357	CbGeAlD
Methotrexate—ABCG2—adrenal cortex—obesity	0.000297	0.0035	CbGeAlD
Methotrexate—AOX1—liver—obesity	0.000294	0.00346	CbGeAlD
Methotrexate—ABCC2—adrenal gland—obesity	0.000294	0.00346	CbGeAlD
Methotrexate—ABCC1—pituitary gland—obesity	0.00029	0.00341	CbGeAlD
Methotrexate—ABCC1—adipose tissue—obesity	0.000289	0.0034	CbGeAlD
Methotrexate—ABCC3—liver—obesity	0.000288	0.00339	CbGeAlD
Methotrexate—ABCC10—liver—obesity	0.000287	0.00337	CbGeAlD
Methotrexate—SLCO1A2—endocrine gland—obesity	0.000274	0.00322	CbGeAlD
Methotrexate—ABCC4—endocrine gland—obesity	0.000264	0.0031	CbGeAlD
Methotrexate—ABCC1—adrenal gland—obesity	0.000259	0.00305	CbGeAlD
Methotrexate—Folic Acid—CYP2E1—obesity	0.000256	0.053	CrCbGaD
Methotrexate—ABCC2—endocrine gland—obesity	0.000255	0.003	CbGeAlD
Methotrexate—SLCO1A2—liver—obesity	0.000247	0.0029	CbGeAlD
Methotrexate—ALB—liver—obesity	0.000246	0.00289	CbGeAlD
Methotrexate—ABCG2—pituitary gland—obesity	0.00024	0.00282	CbGeAlD
Methotrexate—ABCG2—adipose tissue—obesity	0.000239	0.00281	CbGeAlD
Methotrexate—ABCC4—liver—obesity	0.000238	0.00279	CbGeAlD
Methotrexate—ABCC2—liver—obesity	0.00023	0.00271	CbGeAlD
Methotrexate—ABCG2—adrenal gland—obesity	0.000215	0.00252	CbGeAlD
Methotrexate—ABCC1—liver—obesity	0.000203	0.00238	CbGeAlD
Methotrexate—ABCB1—islet of Langerhans—obesity	0.000185	0.00218	CbGeAlD
Methotrexate—ABCB1—respiratory system—obesity	0.000175	0.00205	CbGeAlD
Methotrexate—ABCG2—liver—obesity	0.000168	0.00197	CbGeAlD
Methotrexate—Urinary tract disorder—Bupropion—obesity	0.000162	0.00091	CcSEcCtD
Methotrexate—Urethral disorder—Bupropion—obesity	0.00016	0.000903	CcSEcCtD
Methotrexate—Dysgeusia—Sibutramine—obesity	0.00016	0.000901	CcSEcCtD
Methotrexate—Vision blurred—Orlistat—obesity	0.000159	0.000896	CcSEcCtD
Methotrexate—Visual disturbance—Topiramate—obesity	0.000159	0.000895	CcSEcCtD
Methotrexate—Vomiting—Cimetidine—obesity	0.000159	0.000894	CcSEcCtD
Methotrexate—Back pain—Sibutramine—obesity	0.000158	0.00089	CcSEcCtD
Methotrexate—Visual impairment—Bupropion—obesity	0.000158	0.000888	CcSEcCtD
Methotrexate—Rash—Cimetidine—obesity	0.000157	0.000886	CcSEcCtD
Methotrexate—Dermatitis—Cimetidine—obesity	0.000157	0.000885	CcSEcCtD
Methotrexate—Ill-defined disorder—Orlistat—obesity	0.000157	0.000882	CcSEcCtD
Methotrexate—Headache—Cimetidine—obesity	0.000156	0.00088	CcSEcCtD
Methotrexate—Nausea—Diethylpropion—obesity	0.000156	0.000877	CcSEcCtD
Methotrexate—Erythema multiforme—Bupropion—obesity	0.000155	0.000871	CcSEcCtD
Methotrexate—Vision blurred—Sibutramine—obesity	0.000154	0.000867	CcSEcCtD
Methotrexate—Lethargy—Topiramate—obesity	0.000154	0.000866	CcSEcCtD
Methotrexate—Eye disorder—Bupropion—obesity	0.000153	0.000861	CcSEcCtD
Methotrexate—Tinnitus—Bupropion—obesity	0.000153	0.000859	CcSEcCtD
Methotrexate—Malaise—Orlistat—obesity	0.000152	0.000857	CcSEcCtD
Methotrexate—Cardiac disorder—Bupropion—obesity	0.000152	0.000855	CcSEcCtD
Methotrexate—Vertigo—Orlistat—obesity	0.000152	0.000854	CcSEcCtD
Methotrexate—Ill-defined disorder—Sibutramine—obesity	0.000152	0.000854	CcSEcCtD
Methotrexate—Anaemia—Sibutramine—obesity	0.000151	0.00085	CcSEcCtD
Methotrexate—Osteoarthritis—Topiramate—obesity	0.000151	0.000849	CcSEcCtD
Methotrexate—Angiopathy—Bupropion—obesity	0.000148	0.000836	CcSEcCtD
Methotrexate—Nausea—Cimetidine—obesity	0.000148	0.000835	CcSEcCtD
Methotrexate—Immune system disorder—Bupropion—obesity	0.000148	0.000832	CcSEcCtD
Methotrexate—Mediastinal disorder—Bupropion—obesity	0.000147	0.00083	CcSEcCtD
Methotrexate—Malaise—Sibutramine—obesity	0.000147	0.00083	CcSEcCtD
Methotrexate—Cough—Orlistat—obesity	0.000147	0.00083	CcSEcCtD
Methotrexate—Chills—Bupropion—obesity	0.000147	0.000827	CcSEcCtD
Methotrexate—Vertigo—Sibutramine—obesity	0.000147	0.000827	CcSEcCtD
Methotrexate—ABCB1—adrenal cortex—obesity	0.000147	0.00172	CbGeAlD
Methotrexate—Convulsion—Orlistat—obesity	0.000146	0.000824	CcSEcCtD
Methotrexate—Leukopenia—Sibutramine—obesity	0.000146	0.000824	CcSEcCtD
Methotrexate—Alopecia—Bupropion—obesity	0.000145	0.000814	CcSEcCtD
Methotrexate—Irritability—Topiramate—obesity	0.000144	0.00081	CcSEcCtD
Methotrexate—Myalgia—Orlistat—obesity	0.000144	0.000809	CcSEcCtD
Methotrexate—Chest pain—Orlistat—obesity	0.000144	0.000809	CcSEcCtD
Methotrexate—Mental disorder—Bupropion—obesity	0.000143	0.000807	CcSEcCtD
Methotrexate—Mood swings—Topiramate—obesity	0.000143	0.000804	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000143	0.000804	CcSEcCtD
Methotrexate—Cough—Sibutramine—obesity	0.000143	0.000803	CcSEcCtD
Methotrexate—Malnutrition—Bupropion—obesity	0.000142	0.000802	CcSEcCtD
Methotrexate—Discomfort—Orlistat—obesity	0.000142	0.0008	CcSEcCtD
Methotrexate—Ataxia—Topiramate—obesity	0.000142	0.000798	CcSEcCtD
Methotrexate—Convulsion—Sibutramine—obesity	0.000142	0.000797	CcSEcCtD
Methotrexate—Dysgeusia—Bupropion—obesity	0.000139	0.000786	CcSEcCtD
Methotrexate—Liver function test abnormal—Topiramate—obesity	0.000139	0.000783	CcSEcCtD
Methotrexate—Arthralgia—Sibutramine—obesity	0.000139	0.000783	CcSEcCtD
Methotrexate—Myalgia—Sibutramine—obesity	0.000139	0.000783	CcSEcCtD
Methotrexate—Chest pain—Sibutramine—obesity	0.000139	0.000783	CcSEcCtD
Methotrexate—Anaphylactic shock—Orlistat—obesity	0.000138	0.000776	CcSEcCtD
Methotrexate—Back pain—Bupropion—obesity	0.000138	0.000776	CcSEcCtD
Methotrexate—Discomfort—Sibutramine—obesity	0.000137	0.000774	CcSEcCtD
Methotrexate—Infection—Orlistat—obesity	0.000137	0.000771	CcSEcCtD
Methotrexate—Breast disorder—Topiramate—obesity	0.000136	0.000767	CcSEcCtD
Methotrexate—Toxic epidermal necrolysis—Topiramate—obesity	0.000136	0.000764	CcSEcCtD
Methotrexate—Nervous system disorder—Orlistat—obesity	0.000135	0.000761	CcSEcCtD
Methotrexate—Confusional state—Sibutramine—obesity	0.000134	0.000757	CcSEcCtD
Methotrexate—Vision blurred—Bupropion—obesity	0.000134	0.000756	CcSEcCtD
Methotrexate—Skin disorder—Orlistat—obesity	0.000134	0.000754	CcSEcCtD
Methotrexate—ABCB1—cardiovascular system—obesity	0.000134	0.00157	CbGeAlD
Methotrexate—Anaphylactic shock—Sibutramine—obesity	0.000133	0.000751	CcSEcCtD
Methotrexate—Hyperhidrosis—Orlistat—obesity	0.000133	0.00075	CcSEcCtD
Methotrexate—Infection—Sibutramine—obesity	0.000132	0.000746	CcSEcCtD
Methotrexate—Ill-defined disorder—Bupropion—obesity	0.000132	0.000744	CcSEcCtD
Methotrexate—Anaemia—Bupropion—obesity	0.000132	0.000741	CcSEcCtD
Methotrexate—Thrombocytopenia—Sibutramine—obesity	0.000131	0.000735	CcSEcCtD
Methotrexate—Asthma—Topiramate—obesity	0.00013	0.000733	CcSEcCtD
Methotrexate—Skin disorder—Sibutramine—obesity	0.000129	0.000729	CcSEcCtD
Methotrexate—Eosinophilia—Topiramate—obesity	0.000129	0.000726	CcSEcCtD
Methotrexate—Hyperhidrosis—Sibutramine—obesity	0.000129	0.000726	CcSEcCtD
Methotrexate—Malaise—Bupropion—obesity	0.000128	0.000723	CcSEcCtD
Methotrexate—Vertigo—Bupropion—obesity	0.000128	0.000721	CcSEcCtD
Methotrexate—Pancreatitis—Topiramate—obesity	0.000128	0.000719	CcSEcCtD
Methotrexate—Leukopenia—Bupropion—obesity	0.000127	0.000718	CcSEcCtD
Methotrexate—Anorexia—Sibutramine—obesity	0.000127	0.000716	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Orlistat—obesity	0.000126	0.000707	CcSEcCtD
Methotrexate—Abdominal discomfort—Topiramate—obesity	0.000125	0.000703	CcSEcCtD
Methotrexate—Insomnia—Orlistat—obesity	0.000125	0.000702	CcSEcCtD
Methotrexate—Hypotension—Sibutramine—obesity	0.000125	0.000702	CcSEcCtD
Methotrexate—Cough—Bupropion—obesity	0.000124	0.0007	CcSEcCtD
Methotrexate—Paraesthesia—Orlistat—obesity	0.000124	0.000697	CcSEcCtD
Methotrexate—Pancytopenia—Topiramate—obesity	0.000124	0.000697	CcSEcCtD
Methotrexate—Convulsion—Bupropion—obesity	0.000123	0.000695	CcSEcCtD
Methotrexate—Dysuria—Topiramate—obesity	0.000122	0.000686	CcSEcCtD
Methotrexate—Neutropenia—Topiramate—obesity	0.000122	0.000686	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Sibutramine—obesity	0.000121	0.000684	CcSEcCtD
Methotrexate—Dyspepsia—Orlistat—obesity	0.000121	0.000683	CcSEcCtD
Methotrexate—Arthralgia—Bupropion—obesity	0.000121	0.000683	CcSEcCtD
Methotrexate—Myalgia—Bupropion—obesity	0.000121	0.000683	CcSEcCtD
Methotrexate—Chest pain—Bupropion—obesity	0.000121	0.000683	CcSEcCtD
Methotrexate—Upper respiratory tract infection—Topiramate—obesity	0.000121	0.000682	CcSEcCtD
Methotrexate—Insomnia—Sibutramine—obesity	0.000121	0.000679	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00012	0.000678	CcSEcCtD
Methotrexate—Erectile dysfunction—Topiramate—obesity	0.00012	0.000676	CcSEcCtD
Methotrexate—Discomfort—Bupropion—obesity	0.00012	0.000675	CcSEcCtD
Methotrexate—Decreased appetite—Orlistat—obesity	0.00012	0.000675	CcSEcCtD
Methotrexate—Paraesthesia—Sibutramine—obesity	0.00012	0.000674	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Orlistat—obesity	0.000119	0.00067	CcSEcCtD
Methotrexate—Dyspnoea—Sibutramine—obesity	0.000119	0.000669	CcSEcCtD
Methotrexate—Photosensitivity reaction—Topiramate—obesity	0.000119	0.000669	CcSEcCtD
Methotrexate—Fatigue—Orlistat—obesity	0.000119	0.000669	CcSEcCtD
Methotrexate—Somnolence—Sibutramine—obesity	0.000119	0.000668	CcSEcCtD
Methotrexate—ABCB1—pituitary gland—obesity	0.000118	0.00139	CbGeAlD
Methotrexate—ABCB1—adipose tissue—obesity	0.000118	0.00139	CbGeAlD
Methotrexate—Pain—Orlistat—obesity	0.000118	0.000664	CcSEcCtD
Methotrexate—Dyspepsia—Sibutramine—obesity	0.000117	0.000661	CcSEcCtD
Methotrexate—Confusional state—Bupropion—obesity	0.000117	0.00066	CcSEcCtD
Methotrexate—Pneumonia—Topiramate—obesity	0.000117	0.000658	CcSEcCtD
Methotrexate—Anaphylactic shock—Bupropion—obesity	0.000116	0.000655	CcSEcCtD
Methotrexate—Infestation NOS—Topiramate—obesity	0.000116	0.000654	CcSEcCtD
Methotrexate—Infestation—Topiramate—obesity	0.000116	0.000654	CcSEcCtD
Methotrexate—Decreased appetite—Sibutramine—obesity	0.000116	0.000653	CcSEcCtD
Methotrexate—Depression—Topiramate—obesity	0.000116	0.000652	CcSEcCtD
Methotrexate—Infection—Bupropion—obesity	0.000115	0.00065	CcSEcCtD
Methotrexate—Stevens-Johnson syndrome—Topiramate—obesity	0.000115	0.000648	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Sibutramine—obesity	0.000115	0.000648	CcSEcCtD
Methotrexate—Renal failure—Topiramate—obesity	0.000114	0.000643	CcSEcCtD
Methotrexate—Pain—Sibutramine—obesity	0.000114	0.000642	CcSEcCtD
Methotrexate—Nervous system disorder—Bupropion—obesity	0.000114	0.000642	CcSEcCtD
Methotrexate—Thrombocytopenia—Bupropion—obesity	0.000114	0.000641	CcSEcCtD
Methotrexate—Feeling abnormal—Orlistat—obesity	0.000114	0.000639	CcSEcCtD
Methotrexate—Stomatitis—Topiramate—obesity	0.000113	0.000637	CcSEcCtD
Methotrexate—Skin disorder—Bupropion—obesity	0.000113	0.000636	CcSEcCtD
Methotrexate—Conjunctivitis—Topiramate—obesity	0.000113	0.000636	CcSEcCtD
Methotrexate—Gastrointestinal pain—Orlistat—obesity	0.000113	0.000634	CcSEcCtD
Methotrexate—Hyperhidrosis—Bupropion—obesity	0.000112	0.000633	CcSEcCtD
Methotrexate—ABCB1—digestive system—obesity	0.000111	0.00131	CbGeAlD
Methotrexate—Anorexia—Bupropion—obesity	0.000111	0.000624	CcSEcCtD
Methotrexate—Haematuria—Topiramate—obesity	0.000111	0.000624	CcSEcCtD
Methotrexate—Feeling abnormal—Sibutramine—obesity	0.00011	0.000619	CcSEcCtD
Methotrexate—Epistaxis—Topiramate—obesity	0.00011	0.000617	CcSEcCtD
Methotrexate—Urticaria—Orlistat—obesity	0.000109	0.000616	CcSEcCtD
Methotrexate—Gastrointestinal pain—Sibutramine—obesity	0.000109	0.000614	CcSEcCtD
Methotrexate—Abdominal pain—Orlistat—obesity	0.000109	0.000613	CcSEcCtD
Methotrexate—Body temperature increased—Orlistat—obesity	0.000109	0.000613	CcSEcCtD
Methotrexate—Hypotension—Bupropion—obesity	0.000109	0.000612	CcSEcCtD
Methotrexate—Agranulocytosis—Topiramate—obesity	0.000108	0.00061	CcSEcCtD
Methotrexate—Urticaria—Sibutramine—obesity	0.000106	0.000597	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Bupropion—obesity	0.000106	0.000596	CcSEcCtD
Methotrexate—ABCB1—adrenal gland—obesity	0.000106	0.00124	CbGeAlD
Methotrexate—Abdominal pain—Sibutramine—obesity	0.000105	0.000594	CcSEcCtD
Methotrexate—Body temperature increased—Sibutramine—obesity	0.000105	0.000594	CcSEcCtD
Methotrexate—Insomnia—Bupropion—obesity	0.000105	0.000592	CcSEcCtD
Methotrexate—Haemoglobin—Topiramate—obesity	0.000105	0.00059	CcSEcCtD
Methotrexate—Paraesthesia—Bupropion—obesity	0.000104	0.000588	CcSEcCtD
Methotrexate—Haemorrhage—Topiramate—obesity	0.000104	0.000587	CcSEcCtD
Methotrexate—Hepatitis—Topiramate—obesity	0.000104	0.000587	CcSEcCtD
Methotrexate—Dyspnoea—Bupropion—obesity	0.000104	0.000584	CcSEcCtD
Methotrexate—Pharyngitis—Topiramate—obesity	0.000103	0.000583	CcSEcCtD
Methotrexate—Somnolence—Bupropion—obesity	0.000103	0.000582	CcSEcCtD
Methotrexate—Urinary tract disorder—Topiramate—obesity	0.000103	0.00058	CcSEcCtD
Methotrexate—Dyspepsia—Bupropion—obesity	0.000102	0.000576	CcSEcCtD
Methotrexate—Urethral disorder—Topiramate—obesity	0.000102	0.000575	CcSEcCtD
Methotrexate—Hypersensitivity—Orlistat—obesity	0.000101	0.000572	CcSEcCtD
Methotrexate—Decreased appetite—Bupropion—obesity	0.000101	0.000569	CcSEcCtD
Methotrexate—Visual impairment—Topiramate—obesity	0.0001	0.000566	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Bupropion—obesity	0.0001	0.000565	CcSEcCtD
Methotrexate—Fatigue—Bupropion—obesity	0.0001	0.000564	CcSEcCtD
Methotrexate—Pain—Bupropion—obesity	9.94e-05	0.00056	CcSEcCtD
Methotrexate—Asthenia—Orlistat—obesity	9.88e-05	0.000557	CcSEcCtD
Methotrexate—Erythema multiforme—Topiramate—obesity	9.85e-05	0.000555	CcSEcCtD
Methotrexate—Hypersensitivity—Sibutramine—obesity	9.82e-05	0.000553	CcSEcCtD
Methotrexate—Pruritus—Orlistat—obesity	9.75e-05	0.000549	CcSEcCtD
Methotrexate—Eye disorder—Topiramate—obesity	9.74e-05	0.000549	CcSEcCtD
Methotrexate—Tinnitus—Topiramate—obesity	9.72e-05	0.000547	CcSEcCtD
Methotrexate—Cardiac disorder—Topiramate—obesity	9.67e-05	0.000545	CcSEcCtD
Methotrexate—Feeling abnormal—Bupropion—obesity	9.58e-05	0.000539	CcSEcCtD
Methotrexate—Asthenia—Sibutramine—obesity	9.57e-05	0.000539	CcSEcCtD
Methotrexate—Gastrointestinal pain—Bupropion—obesity	9.5e-05	0.000535	CcSEcCtD
Methotrexate—Angiopathy—Topiramate—obesity	9.46e-05	0.000533	CcSEcCtD
Methotrexate—Pruritus—Sibutramine—obesity	9.43e-05	0.000531	CcSEcCtD
Methotrexate—Diarrhoea—Orlistat—obesity	9.43e-05	0.000531	CcSEcCtD
Methotrexate—Immune system disorder—Topiramate—obesity	9.41e-05	0.00053	CcSEcCtD
Methotrexate—Mediastinal disorder—Topiramate—obesity	9.39e-05	0.000529	CcSEcCtD
Methotrexate—Chills—Topiramate—obesity	9.35e-05	0.000527	CcSEcCtD
Methotrexate—Urticaria—Bupropion—obesity	9.23e-05	0.00052	CcSEcCtD
Methotrexate—Alopecia—Topiramate—obesity	9.21e-05	0.000519	CcSEcCtD
Methotrexate—Body temperature increased—Bupropion—obesity	9.19e-05	0.000518	CcSEcCtD
Methotrexate—Abdominal pain—Bupropion—obesity	9.19e-05	0.000518	CcSEcCtD
Methotrexate—ABCB1—endocrine gland—obesity	9.18e-05	0.00108	CbGeAlD
Methotrexate—Mental disorder—Topiramate—obesity	9.13e-05	0.000514	CcSEcCtD
Methotrexate—Diarrhoea—Sibutramine—obesity	9.12e-05	0.000514	CcSEcCtD
Methotrexate—Dizziness—Orlistat—obesity	9.11e-05	0.000513	CcSEcCtD
Methotrexate—Malnutrition—Topiramate—obesity	9.07e-05	0.000511	CcSEcCtD
Methotrexate—Erythema—Topiramate—obesity	9.07e-05	0.000511	CcSEcCtD
Methotrexate—Dysgeusia—Topiramate—obesity	8.88e-05	0.0005	CcSEcCtD
Methotrexate—Dizziness—Sibutramine—obesity	8.82e-05	0.000497	CcSEcCtD
Methotrexate—Back pain—Topiramate—obesity	8.78e-05	0.000494	CcSEcCtD
Methotrexate—Vomiting—Orlistat—obesity	8.76e-05	0.000493	CcSEcCtD
Methotrexate—Rash—Orlistat—obesity	8.69e-05	0.000489	CcSEcCtD
Methotrexate—Dermatitis—Orlistat—obesity	8.68e-05	0.000489	CcSEcCtD
Methotrexate—Headache—Orlistat—obesity	8.63e-05	0.000486	CcSEcCtD
Methotrexate—Hypersensitivity—Bupropion—obesity	8.56e-05	0.000482	CcSEcCtD
Methotrexate—Vision blurred—Topiramate—obesity	8.55e-05	0.000482	CcSEcCtD
Methotrexate—Vomiting—Sibutramine—obesity	8.48e-05	0.000477	CcSEcCtD
Methotrexate—Ill-defined disorder—Topiramate—obesity	8.42e-05	0.000474	CcSEcCtD
Methotrexate—Rash—Sibutramine—obesity	8.41e-05	0.000473	CcSEcCtD
Methotrexate—Dermatitis—Sibutramine—obesity	8.4e-05	0.000473	CcSEcCtD
Methotrexate—Anaemia—Topiramate—obesity	8.39e-05	0.000472	CcSEcCtD
Methotrexate—Headache—Sibutramine—obesity	8.35e-05	0.00047	CcSEcCtD
Methotrexate—Asthenia—Bupropion—obesity	8.34e-05	0.00047	CcSEcCtD
Methotrexate—ABCB1—liver—obesity	8.27e-05	0.000973	CbGeAlD
Methotrexate—Pruritus—Bupropion—obesity	8.22e-05	0.000463	CcSEcCtD
Methotrexate—Nausea—Orlistat—obesity	8.18e-05	0.000461	CcSEcCtD
Methotrexate—Malaise—Topiramate—obesity	8.18e-05	0.000461	CcSEcCtD
Methotrexate—Vertigo—Topiramate—obesity	8.15e-05	0.000459	CcSEcCtD
Methotrexate—Leukopenia—Topiramate—obesity	8.12e-05	0.000457	CcSEcCtD
Methotrexate—Diarrhoea—Bupropion—obesity	7.95e-05	0.000448	CcSEcCtD
Methotrexate—Nausea—Sibutramine—obesity	7.92e-05	0.000446	CcSEcCtD
Methotrexate—Cough—Topiramate—obesity	7.92e-05	0.000446	CcSEcCtD
Methotrexate—Convulsion—Topiramate—obesity	7.86e-05	0.000443	CcSEcCtD
Methotrexate—Myalgia—Topiramate—obesity	7.72e-05	0.000435	CcSEcCtD
Methotrexate—Arthralgia—Topiramate—obesity	7.72e-05	0.000435	CcSEcCtD
Methotrexate—Chest pain—Topiramate—obesity	7.72e-05	0.000435	CcSEcCtD
Methotrexate—Dizziness—Bupropion—obesity	7.69e-05	0.000433	CcSEcCtD
Methotrexate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	7.67e-05	0.000432	CcSEcCtD
Methotrexate—Discomfort—Topiramate—obesity	7.63e-05	0.00043	CcSEcCtD
Methotrexate—Confusional state—Topiramate—obesity	7.47e-05	0.000421	CcSEcCtD
Methotrexate—Vomiting—Bupropion—obesity	7.39e-05	0.000416	CcSEcCtD
Methotrexate—Infection—Topiramate—obesity	7.36e-05	0.000414	CcSEcCtD
Methotrexate—Rash—Bupropion—obesity	7.33e-05	0.000413	CcSEcCtD
Methotrexate—Dermatitis—Bupropion—obesity	7.32e-05	0.000412	CcSEcCtD
Methotrexate—Headache—Bupropion—obesity	7.28e-05	0.00041	CcSEcCtD
Methotrexate—Nervous system disorder—Topiramate—obesity	7.26e-05	0.000409	CcSEcCtD
Methotrexate—Thrombocytopenia—Topiramate—obesity	7.25e-05	0.000408	CcSEcCtD
Methotrexate—Skin disorder—Topiramate—obesity	7.19e-05	0.000405	CcSEcCtD
Methotrexate—Hyperhidrosis—Topiramate—obesity	7.16e-05	0.000403	CcSEcCtD
Methotrexate—Anorexia—Topiramate—obesity	7.06e-05	0.000398	CcSEcCtD
Methotrexate—Hypotension—Topiramate—obesity	6.92e-05	0.00039	CcSEcCtD
Methotrexate—Nausea—Bupropion—obesity	6.9e-05	0.000389	CcSEcCtD
Methotrexate—Musculoskeletal discomfort—Topiramate—obesity	6.75e-05	0.00038	CcSEcCtD
Methotrexate—Insomnia—Topiramate—obesity	6.7e-05	0.000377	CcSEcCtD
Methotrexate—Paraesthesia—Topiramate—obesity	6.65e-05	0.000375	CcSEcCtD
Methotrexate—Dyspnoea—Topiramate—obesity	6.6e-05	0.000372	CcSEcCtD
Methotrexate—Somnolence—Topiramate—obesity	6.58e-05	0.000371	CcSEcCtD
Methotrexate—Dyspepsia—Topiramate—obesity	6.52e-05	0.000367	CcSEcCtD
Methotrexate—Decreased appetite—Topiramate—obesity	6.44e-05	0.000363	CcSEcCtD
Methotrexate—Gastrointestinal disorder—Topiramate—obesity	6.39e-05	0.00036	CcSEcCtD
Methotrexate—Fatigue—Topiramate—obesity	6.38e-05	0.00036	CcSEcCtD
Methotrexate—Pain—Topiramate—obesity	6.33e-05	0.000357	CcSEcCtD
Methotrexate—Feeling abnormal—Topiramate—obesity	6.1e-05	0.000344	CcSEcCtD
Methotrexate—Gastrointestinal pain—Topiramate—obesity	6.05e-05	0.000341	CcSEcCtD
Methotrexate—Urticaria—Topiramate—obesity	5.88e-05	0.000331	CcSEcCtD
Methotrexate—Abdominal pain—Topiramate—obesity	5.85e-05	0.00033	CcSEcCtD
Methotrexate—Body temperature increased—Topiramate—obesity	5.85e-05	0.00033	CcSEcCtD
Methotrexate—Hypersensitivity—Topiramate—obesity	5.46e-05	0.000307	CcSEcCtD
Methotrexate—Asthenia—Topiramate—obesity	5.31e-05	0.000299	CcSEcCtD
Methotrexate—Pruritus—Topiramate—obesity	5.24e-05	0.000295	CcSEcCtD
Methotrexate—Diarrhoea—Topiramate—obesity	5.07e-05	0.000285	CcSEcCtD
Methotrexate—Dizziness—Topiramate—obesity	4.9e-05	0.000276	CcSEcCtD
Methotrexate—Vomiting—Topiramate—obesity	4.71e-05	0.000265	CcSEcCtD
Methotrexate—Rash—Topiramate—obesity	4.67e-05	0.000263	CcSEcCtD
Methotrexate—Dermatitis—Topiramate—obesity	4.66e-05	0.000263	CcSEcCtD
Methotrexate—Headache—Topiramate—obesity	4.64e-05	0.000261	CcSEcCtD
Methotrexate—Nausea—Topiramate—obesity	4.4e-05	0.000248	CcSEcCtD
Methotrexate—TYMS—Metabolism—PIK3CB—obesity	2.7e-06	1.54e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IRS1—obesity	2.69e-06	1.53e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—PIK3CD—obesity	2.69e-06	1.53e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PPARG—obesity	2.69e-06	1.53e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GCK—obesity	2.69e-06	1.53e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—LIPC—obesity	2.69e-06	1.53e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PIK3R1—obesity	2.68e-06	1.53e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—NOS3—obesity	2.68e-06	1.53e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PTGS2—obesity	2.67e-06	1.52e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APOC3—obesity	2.67e-06	1.52e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PPARA—obesity	2.67e-06	1.52e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.66e-06	1.52e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—SERPINE1—obesity	2.66e-06	1.51e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—LPL—obesity	2.66e-06	1.51e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—MYC—obesity	2.65e-06	1.51e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—POMC—obesity	2.65e-06	1.51e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—TGFB1—obesity	2.64e-06	1.51e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SULT2A1—obesity	2.64e-06	1.5e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GLP1R—obesity	2.64e-06	1.5e-05	CbGpPWpGaD
Methotrexate—PGD—Metabolism—AKT1—obesity	2.63e-06	1.5e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—DPYD—obesity	2.6e-06	1.48e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GPX1—obesity	2.59e-06	1.48e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CETP—obesity	2.59e-06	1.48e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—MTHFR—obesity	2.58e-06	1.47e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—AGT—obesity	2.58e-06	1.47e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—INS—obesity	2.58e-06	1.47e-05	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—AKT1—obesity	2.58e-06	1.47e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—RHOA—obesity	2.56e-06	1.46e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SDC1—obesity	2.56e-06	1.46e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PIK3CD—obesity	2.56e-06	1.46e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—APOA1—obesity	2.54e-06	1.45e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NOS3—obesity	2.54e-06	1.45e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—PIK3R1—obesity	2.54e-06	1.45e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PIK3CG—obesity	2.54e-06	1.45e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PPARA—obesity	2.53e-06	1.44e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—PIK3CA—obesity	2.53e-06	1.44e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—APOE—obesity	2.53e-06	1.44e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ALB—obesity	2.53e-06	1.44e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CD36—obesity	2.52e-06	1.44e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—AKR1C3—obesity	2.52e-06	1.44e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CAV1—obesity	2.51e-06	1.43e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—APOA1—obesity	2.5e-06	1.42e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PRKAR2B—obesity	2.5e-06	1.42e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—AKT2—obesity	2.49e-06	1.42e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—DCN—obesity	2.48e-06	1.41e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SCARB1—obesity	2.48e-06	1.41e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PIK3CB—obesity	2.47e-06	1.41e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—PIK3CA—obesity	2.47e-06	1.41e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—AGT—obesity	2.45e-06	1.4e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PTGS2—obesity	2.45e-06	1.4e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PPARG—obesity	2.45e-06	1.39e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PIK3CD—obesity	2.45e-06	1.39e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PIK3R1—obesity	2.42e-06	1.38e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—NOS3—obesity	2.42e-06	1.38e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—POMC—obesity	2.42e-06	1.38e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CPT1A—obesity	2.41e-06	1.38e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SREBF1—obesity	2.41e-06	1.37e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—APOE—obesity	2.4e-06	1.37e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—INS—obesity	2.4e-06	1.37e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PIK3CD—obesity	2.4e-06	1.37e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.39e-06	1.36e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—MTHFR—obesity	2.39e-06	1.36e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CAV1—obesity	2.38e-06	1.36e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—APOA1—obesity	2.38e-06	1.35e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—SERPINE1—obesity	2.37e-06	1.35e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NAMPT—obesity	2.37e-06	1.35e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—LIPC—obesity	2.35e-06	1.34e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GCK—obesity	2.35e-06	1.34e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PPARA—obesity	2.35e-06	1.34e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GOT2—obesity	2.34e-06	1.33e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—PIK3CB—obesity	2.34e-06	1.33e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APOC3—obesity	2.34e-06	1.33e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PIK3R1—obesity	2.31e-06	1.32e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—TYK2—obesity	2.31e-06	1.31e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—FASN—obesity	2.29e-06	1.31e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—RHOA—obesity	2.29e-06	1.3e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—BCHE—obesity	2.28e-06	1.3e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PIK3CG—obesity	2.28e-06	1.3e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.28e-06	1.3e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—AGT—obesity	2.27e-06	1.29e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CETP—obesity	2.27e-06	1.29e-05	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—AKT1—obesity	2.26e-06	1.29e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NOS3—obesity	2.26e-06	1.29e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PIK3R1—obesity	2.26e-06	1.29e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—PIK3CA—obesity	2.25e-06	1.28e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SDC1—obesity	2.24e-06	1.28e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—IL6—obesity	2.24e-06	1.28e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PIK3CB—obesity	2.23e-06	1.27e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PIK3CD—obesity	2.23e-06	1.27e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—obesity	2.23e-06	1.27e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—APOE—obesity	2.23e-06	1.27e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PTGS2—obesity	2.21e-06	1.26e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—AKR1C3—obesity	2.21e-06	1.26e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CAV1—obesity	2.21e-06	1.26e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PPARG—obesity	2.2e-06	1.26e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CYP2E1—obesity	2.2e-06	1.25e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ALB—obesity	2.2e-06	1.25e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—APOA1—obesity	2.2e-06	1.25e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—IL6—obesity	2.19e-06	1.25e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NQO1—obesity	2.18e-06	1.24e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SCARB1—obesity	2.17e-06	1.24e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—POMC—obesity	2.17e-06	1.24e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PIK3CG—obesity	2.17e-06	1.24e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—INS—obesity	2.16e-06	1.23e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PIK3CB—obesity	2.13e-06	1.21e-05	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PIK3CA—obesity	2.12e-06	1.21e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PTGS2—obesity	2.11e-06	1.2e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SREBF1—obesity	2.11e-06	1.2e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PIK3R1—obesity	2.11e-06	1.2e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—NOS3—obesity	2.11e-06	1.2e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PPARG—obesity	2.09e-06	1.19e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MTOR—obesity	2.09e-06	1.19e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PIK3CB—obesity	2.09e-06	1.19e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GCG—obesity	2.09e-06	1.19e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SLC2A4—obesity	2.09e-06	1.19e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PIK3CA—obesity	2.07e-06	1.18e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PTGS2—obesity	2.07e-06	1.18e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—AKT1—obesity	2.07e-06	1.18e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—POMC—obesity	2.07e-06	1.18e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CYCS—obesity	2.06e-06	1.17e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—INS—obesity	2.05e-06	1.17e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GOT2—obesity	2.05e-06	1.17e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GOT1—obesity	2.02e-06	1.15e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GGT1—obesity	2.02e-06	1.15e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—AKT1—obesity	2.02e-06	1.15e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—ALB—obesity	2.01e-06	1.15e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PIK3CG—obesity	2.01e-06	1.14e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—FASN—obesity	2.01e-06	1.14e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PIK3CD—obesity	2.01e-06	1.14e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—BCHE—obesity	2e-06	1.14e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—IL6—obesity	1.99e-06	1.13e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NCOA1—obesity	1.99e-06	1.13e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ALB—obesity	1.98e-06	1.13e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CYP19A1—obesity	1.96e-06	1.12e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—STK11—obesity	1.96e-06	1.12e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PIK3CB—obesity	1.94e-06	1.11e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PPARG—obesity	1.94e-06	1.1e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CYP2E1—obesity	1.93e-06	1.1e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PTGS2—obesity	1.93e-06	1.1e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—POMC—obesity	1.91e-06	1.09e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NQO1—obesity	1.91e-06	1.09e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PIK3CD—obesity	1.91e-06	1.09e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—INS—obesity	1.9e-06	1.08e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PIK3R1—obesity	1.9e-06	1.08e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—NOS3—obesity	1.9e-06	1.08e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PIK3CA—obesity	1.88e-06	1.07e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ALB—obesity	1.88e-06	1.07e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—AKT1—obesity	1.84e-06	1.05e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SLC2A4—obesity	1.83e-06	1.04e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GCG—obesity	1.83e-06	1.04e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—COMT—obesity	1.83e-06	1.04e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CYCS—obesity	1.81e-06	1.03e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—NOS3—obesity	1.8e-06	1.03e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PIK3R1—obesity	1.8e-06	1.03e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GNB3—obesity	1.8e-06	1.03e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PPARGC1A—obesity	1.8e-06	1.03e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—HMOX1—obesity	1.79e-06	1.02e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GGT1—obesity	1.77e-06	1.01e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GOT1—obesity	1.77e-06	1.01e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PIK3CD—obesity	1.77e-06	1.01e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GNAS—obesity	1.75e-06	9.98e-06	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PIK3CB—obesity	1.75e-06	9.96e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NCOA1—obesity	1.75e-06	9.94e-06	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ALB—obesity	1.74e-06	9.93e-06	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PTGS2—obesity	1.73e-06	9.87e-06	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—AKT1—obesity	1.73e-06	9.87e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—STK11—obesity	1.72e-06	9.8e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CYP19A1—obesity	1.72e-06	9.8e-06	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PIK3CA—obesity	1.72e-06	9.78e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APOB—obesity	1.72e-06	9.78e-06	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—AKT1—obesity	1.69e-06	9.64e-06	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TGFB1—obesity	1.68e-06	9.56e-06	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PIK3R1—obesity	1.67e-06	9.5e-06	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—NOS3—obesity	1.67e-06	9.5e-06	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PIK3CB—obesity	1.66e-06	9.47e-06	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PTGS2—obesity	1.65e-06	9.38e-06	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PIK3CA—obesity	1.64e-06	9.37e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—LPL—obesity	1.64e-06	9.33e-06	CbGpPWpGaD
Methotrexate—ABCC1—Disease—STAT3—obesity	1.61e-06	9.2e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—COMT—obesity	1.6e-06	9.11e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GPX1—obesity	1.6e-06	9.11e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PPARGC1A—obesity	1.58e-06	8.98e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GNB3—obesity	1.58e-06	8.98e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—HMOX1—obesity	1.57e-06	8.94e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CD36—obesity	1.56e-06	8.87e-06	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—AKT1—obesity	1.54e-06	8.77e-06	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PIK3CB—obesity	1.54e-06	8.77e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GNAS—obesity	1.54e-06	8.75e-06	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PTGS2—obesity	1.53e-06	8.69e-06	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PIK3CA—obesity	1.51e-06	8.59e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APOB—obesity	1.5e-06	8.56e-06	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MYC—obesity	1.5e-06	8.54e-06	CbGpPWpGaD
Methotrexate—ABCC1—Disease—TGFB1—obesity	1.5e-06	8.52e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—MTHFR—obesity	1.48e-06	8.4e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PPARA—obesity	1.45e-06	8.24e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—LPL—obesity	1.44e-06	8.18e-06	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—PIK3CA—obesity	1.43e-06	8.13e-06	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—AKT1—obesity	1.4e-06	7.99e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—AGT—obesity	1.4e-06	7.99e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GPX1—obesity	1.4e-06	7.98e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APOE—obesity	1.37e-06	7.82e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CD36—obesity	1.36e-06	7.77e-06	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PIK3CA—obesity	1.36e-06	7.75e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CAV1—obesity	1.36e-06	7.75e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—APOA1—obesity	1.36e-06	7.73e-06	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—AKT1—obesity	1.34e-06	7.65e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.3e-06	7.41e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—MTHFR—obesity	1.29e-06	7.36e-06	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PIK3CA—obesity	1.27e-06	7.25e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PPARA—obesity	1.27e-06	7.22e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PIK3CG—obesity	1.24e-06	7.06e-06	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—AKT1—obesity	1.23e-06	7.02e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—AGT—obesity	1.23e-06	7e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APOE—obesity	1.2e-06	6.86e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PPARG—obesity	1.2e-06	6.81e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CAV1—obesity	1.19e-06	6.79e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—APOA1—obesity	1.19e-06	6.78e-06	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PIK3CA—obesity	1.19e-06	6.75e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—POMC—obesity	1.18e-06	6.72e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—INS—obesity	1.17e-06	6.68e-06	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—AKT1—obesity	1.17e-06	6.65e-06	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IL6—obesity	1.13e-06	6.42e-06	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—AKT1—obesity	1.11e-06	6.33e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PIK3CD—obesity	1.09e-06	6.21e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PIK3CG—obesity	1.09e-06	6.19e-06	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PIK3CA—obesity	1.07e-06	6.07e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PPARG—obesity	1.05e-06	5.97e-06	CbGpPWpGaD
Methotrexate—ABCC1—Disease—AKT1—obesity	1.04e-06	5.93e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—POMC—obesity	1.03e-06	5.89e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PIK3R1—obesity	1.03e-06	5.86e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—NOS3—obesity	1.03e-06	5.86e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—INS—obesity	1.03e-06	5.86e-06	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PIK3CA—obesity	1.01e-06	5.77e-06	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—AKT1—obesity	9.68e-07	5.51e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PIK3CD—obesity	9.55e-07	5.44e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PIK3CB—obesity	9.5e-07	5.41e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ALB—obesity	9.43e-07	5.37e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PTGS2—obesity	9.41e-07	5.36e-06	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PIK3CA—obesity	9.38e-07	5.35e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—NOS3—obesity	9.02e-07	5.14e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PIK3R1—obesity	9.02e-07	5.14e-06	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—AKT1—obesity	8.71e-07	4.96e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PIK3CB—obesity	8.32e-07	4.74e-06	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—AKT1—obesity	8.28e-07	4.72e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PTGS2—obesity	8.25e-07	4.7e-06	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—AKT1—obesity	7.67e-07	4.37e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PIK3CA—obesity	5.79e-07	3.3e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PIK3CA—obesity	5.07e-07	2.89e-06	CbGpPWpGaD
Methotrexate—ALB—Metabolism—AKT1—obesity	4.73e-07	2.69e-06	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—AKT1—obesity	4.14e-07	2.36e-06	CbGpPWpGaD
